Efficacy and Safety of Selinexor in Recurrent Glioblastoma

被引：0
|
作者：
Lassman, A. B. [1 ]
Wen, P. Y. [2 ]
van den Bent, M. [3 ]
Plotkin, S. R. [4 ]
Walenkamp, A. [5 ]
Green, A. [2 ,6 ]
Huang, X. [7 ]
Rodriguez-Lopez, K. Karla [7 ]
Kauffman, M. G. [7 ]
Shacham, S. [7 ]
Mau-Soerensen, M. [8 ]
机构：
[1] Columbia Univ, Irving Med Ctr, New York, NY USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Erasmus MC Canc Ctr, Rotterdam, Netherlands
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Univ Groningen, Groningen, Netherlands
[6] Univ Colorado, Ctr Canc, Aurora, CO USA
[7] Karyopharm Therapeut Inc, Newton, MA USA
[8] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
来源：
NEUROTHERAPEUTICS | 2020年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
12
引用
收藏
页码：1315 / 1316
页数：2
相关论文
共 50 条
  • [41] The Efficacy and Safety of Adjuvant Lomustine to Chemotherapy for Recurrent Glioblastoma: A Meta-analysis of Randomized Controlled Studies
    Fu, Xiaojuan
    Shi, Dijian
    Feng, Yimo
    CLINICAL NEUROPHARMACOLOGY, 2022, 45 (06) : 162 - 167
  • [42] The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma
    D'Amico, Randy S.
    Cloney, Michael B.
    Sonabend, Adam M.
    Zacharia, Brad
    Nazarian, Matthew N.
    Iwamoto, Fabio M.
    Sisti, Michael B.
    Bruce, Jeffrey N.
    McKhann, Guy M., II
    WORLD NEUROSURGERY, 2015, 84 (04) : 913 - 919
  • [43] Safety of axitinib plus avelumab in patients with recurrent glioblastoma
    Ben Salama, Laila
    Duerinck, Johnny
    Du Four, Stephanie
    Awada, Gil
    Fischbuch, Lydia
    De Cremer, Jennifer
    Rogiers, Anne
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
    Lukas, Rimas V.
    Rodon, Jordi
    Becker, Kevin
    Wong, Eric T.
    Shih, Kent
    Touat, Mehdi
    Fasso, Marcella
    Osborne, Stuart
    Molinero, Luciana
    O'Hear, Carol
    Grossman, William
    Baehring, Joachim
    JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (02) : 317 - 328
  • [45] Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
    Rimas V. Lukas
    Jordi Rodon
    Kevin Becker
    Eric T. Wong
    Kent Shih
    Mehdi Touat
    Marcella Fassò
    Stuart Osborne
    Luciana Molinero
    Carol O’Hear
    William Grossman
    Joachim Baehring
    Journal of Neuro-Oncology, 2018, 140 : 317 - 328
  • [46] Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM).
    Reardon, David A.
    De Groot, John Frederick
    Colman, Howard
    Jordan, Justin T.
    Daras, Mariza
    Clarke, Jennifer Leigh
    Nghiemphu, Phioanh Leia
    Gaffey, Sarah C.
    Peters, Katherine B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Efficacy and safety of bevacizumab for the treatment of glioblastoma (Review)
    Yu, Zhiyun
    Zhao, Gang
    Zhang, Zhonghua
    Li, Yunqian
    Chen, Yong
    Wang, Nan
    Zhao, Zhongying
    Xie, Guifang
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (02) : 371 - 380
  • [48] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
    J. N. Jakobsen
    T. Urup
    K. Grunnet
    A. Toft
    M. D. Johansen
    S. H. Poulsen
    I. J. Christensen
    A. Muhic
    H. S. Poulsen
    Journal of Neuro-Oncology, 2018, 137 : 439 - 446
  • [49] Dose-dependent efficacy of bevacizumab in recurrent glioblastoma
    Melhem, Jawad M.
    Tahir, Ali
    Calabrese, Eirena
    Granovskaya, Inga
    Atenafu, Eshetu G.
    Sahgal, Arjun
    Lim-Fat, Mary Jane
    Perry, James R.
    JOURNAL OF NEURO-ONCOLOGY, 2023, 161 (03) : 633 - 641
  • [50] Comparative Efficacy of Bevacizumab and PCV Chemotherapy in Recurrent Glioblastoma
    Dixit, S.
    Hingorani, M.
    CLINICAL ONCOLOGY, 2015, 27 (04) : 246 - 247
12345